Factors Associated With Readmissions Following Left Ventricular Assist Device Implantation

被引:0
|
作者
Eisenga, John B. [1 ,2 ,3 ]
Mccullough, Kyle A. [1 ,2 ]
Afzal, Aasim [1 ]
Dimaio, J. Michael [1 ,4 ]
Moubarak, Ghadi [1 ,2 ]
Milligan, Greg [1 ]
Kabra, Nitin [1 ]
Rusia, Akash [1 ]
Rawitscher, David A. [1 ]
George, Timothy J. [1 ]
机构
[1] Baylor Scott & White, Heart Hosp, Plano, TX USA
[2] Baylor Scott & White Res Inst, Dallas, TX USA
[3] Baylor Univ, Med Ctr, Dallas, TX USA
[4] Texas A&M Univ, Dept Biomed Engn, College Stn, TX USA
关键词
Heart failure; LVAD; NYHA; Outcomes; Readmission; HOSPITAL READMISSIONS; HEART-FAILURE; IMPACT;
D O I
10.1016/j.jss.2025.02.009
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction: While left ventricular device implantation has been shown to improve both survival and quality of life in patients with end stage heart failure, these patients have a high rate of readmissions to the hospital. The incidence and factors associated with readmission are poorly characterized in the destination therapy population. Methods: All patients who underwent HeartMate III left ventricular assist device therapy (LVAD) implantation at our facility from 2017 to 2023 were identified. Patients undergoing primary LVAD implantation were included. Primary outcome was readmission for any reason. Multivariable linear regression was utilized to identify predictors of readmissions. Results: From 2017 to 2023, 151 primary LVAD implantations were performed with 12 (8.0%) perioperative moralities (defined as index implant hospitalization mortality). The 139 remaining patients suffered 456 separate readmissions with a median follow-up of 590 (303-1002) ds and a total follow-up of 270.7 patient-ys for a rate of 1.7 readmissions per patient-y. The most common cause of readmission was heart failure exacerbation (27.0%), major infection (17.8%), and major bleeding (13.6%). Patients who were readmitted within 6 mos were more likely to have New York Heart Association class III or IV symptoms compared to those who had not been readmitted 39.1% versus 11.8% versus 15%, P = 0.0008. On multivariable linear regression, increasing body mass index (P = 0.02), increased preoperative bilirubin (P = 0.04), and increased follow-up time (P < 0.01) were predictive of the need for readmissions. Conclusions: Following LVAD implantation, readmissions within 6 mos of surgery are associated with worse functional status at 6 mos and 1 y postoperatively. Increased body mass index and preoperative bilirubin were associated with more frequent readmissions. (c) 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:202 / 208
页数:7
相关论文
共 50 条
  • [1] Home Monitoring is Associated With Fewer Hospital Readmissions Following Left Ventricular Assist Device Implantation
    Psotka, Mitchell A.
    Svetlichnaya, Jana
    Kassemos, Michele
    Kobasic, Krystal
    McClure, Kelly
    Sharma, Sonia
    Nam, Yuri
    Selby, Van N.
    Janmohamed, Munir
    De Marco, Teresa
    Wieselthaler, Georg
    Klein, Liviu
    CIRCULATION, 2016, 134
  • [2] Readmissions Following Implantation of a Continuous-Flow Left Ventricular Assist Device
    Da Silva, Matthew
    MacIver, Jane
    Rodger, Marnie
    Jaffer, M. N. Munira
    Raju, Sneha
    Billia, Filio
    Rao, Vivek
    JOURNAL OF CARDIAC SURGERY, 2016, 31 (05) : 361 - 364
  • [3] Hospital Readmissions After Left Ventricular Assist Device Implantation
    Heim, C.
    Mekkhala, N.
    Kondruweit, M.
    Weyand, M.
    Tandler, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S340 - S341
  • [4] Hospital readmissions after left ventricular assist device implantation
    Lesny, P.
    Luknar, M.
    Simovicova, V.
    Dankova, M.
    Goncalvesova, E.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 91 - 91
  • [5] Hospital readmissions after left ventricular assist device implantation
    Heim, Christian
    Mekkhala, Nattipong
    Kondruweit, Markus
    Weyand, Michael
    Tandler, Rene
    TRANSPLANTATION, 2016, 100 (07) : S41 - S41
  • [6] Readmissions After Implantation of Axial Flow Left Ventricular Assist Device
    Hasin, Tal
    Marmor, Yariv
    Kremers, Walter
    Topilsky, Yan
    Severson, Cathy J.
    Schirger, John A.
    Boilson, Barry A.
    Clavell, Alfredo L.
    Rodeheffer, Richard J.
    Frantz, Robert P.
    Edwards, Brooks S.
    Pereira, Naveen L.
    Stulak, John M.
    Joyce, Lyle
    Daly, Richard
    Park, Soon J.
    Kushwaha, Sudhir S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (02) : 153 - 163
  • [7] Readmissions after continuous flow left ventricular assist device implantation
    Mitsutoshi Kimura
    Kan Nawata
    Osamu Kinoshita
    Haruo Yamauchi
    Yasuhiro Hoshino
    Masaru Hatano
    Eisuke Amiya
    Koichi Kashiwa
    Miyoko Endo
    Yukie Kagami
    Mariko Nemoto
    Minoru Ono
    Journal of Artificial Organs, 2017, 20 : 311 - 317
  • [8] Readmissions after continuous flow left ventricular assist device implantation
    Kimura, Mitsutoshi
    Nawata, Kan
    Kinoshita, Osamu
    Yamauchi, Haruo
    Hoshino, Yasuhiro
    Hatano, Masaru
    Amiya, Eisuke
    Kashiwa, Koichi
    Endo, Miyoko
    Kagami, Yukie
    Nemoto, Mariko
    Ono, Minoru
    JOURNAL OF ARTIFICIAL ORGANS, 2017, 20 (04) : 311 - 317
  • [9] Factors determining post-operative readmissions after left ventricular assist device implantation
    Tsiouris, Athanasios
    Paone, Gaetano
    Nemeh, Hassan W.
    Brewer, Robert J.
    Morgan, Jeffrey A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (10): : 1041 - 1047
  • [10] Readmissions Following Implantation of Axial Flow Left Ventricular Assist Devices
    Hasin, T.
    Marmor, Y.
    Topilsky, Y.
    Schirger, J. A.
    Boilson, B. A.
    Clavell, A. L.
    Rodeheffer, R. J.
    Frantz, R. P.
    Edwards, B. S.
    Pereira, N. L.
    Joyce, L.
    Richard, D.
    Park, S. J.
    Kushwaha, S. S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S196 - S196